S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving drugs in different ways may
kill more cancer cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy given in
different ways in treating patients with surgically removed stage II or stage III colon
cancer at high risk of recurrence.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI) North Central Cancer Treatment Group